METHODS AND RESULTS: A total of 60 consecutive patients with infrapopliteal arterial obstructions were treated by
stent implantation into the tibial and peroneal arteries and the data was entered into a prospective registry. All patients were treated with balloon-expandable coronary
stents with a
stent length of 33 mm and a nominal diameter of 3.5 mm. Enrolment was limited to patients treatable with a single
stent. 30 patients (56.7% male, mean age 71.4 years, 83.3% diabetics) received a
sirolimus-eluting balloon-expandable
stent. 30 patients (63.3% male, mean age 73.0 years, 76.6% diabetics) were treated with uncoated bare-
metal stents. At follow-up, the cumulative rates of Major Adverse Events were 10.0% vs. 46.6%. The rates of major
amputation, bypass surgery or Target Lesion Revascularisation (TLR) were all zero for the
sirolimus group compared with 10.0%, 0% and 23.3% in the bare
metal stent group. There were 7 deaths (
sirolimus =3, bare
metal =7). Angiographic follow-up comparing
sirolimus vs. bare
metal revealed
stent occlusion 0% vs. 17.4%, restenosis >50% of 0% vs. 39.1% (p 0.0007) and mean degree of in-
stent restenosis of 1.8+/-4.8% vs. 53+/-40.9% (p <0.0001) respectively.
CONCLUSION: